Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00933992

Ligand	Ligand name	Chain	PDB	Tanimoto
OHT	4-HYDROXYTAMOXIFEN	A	3ERT	0.7
OHT	4-HYDROXYTAMOXIFEN	A,B	1S9Q	0.7
OHT	4-HYDROXYTAMOXIFEN	A,B	1VJB	0.7
OHT	4-HYDROXYTAMOXIFEN	A,B,C,P,R	2JF9	0.7
OHT	4-HYDROXYTAMOXIFEN	A,B,C,D,E,F	2GPV	0.7
OHT	4-HYDROXYTAMOXIFEN	A	2GPU	0.7
OHT	4-HYDROXYTAMOXIFEN	A	2P7Z	0.7
OHT	4-HYDROXYTAMOXIFEN	A,B	2BJ4	0.7
OHT	4-HYDROXYTAMOXIFEN	A,B	2FSZ	0.7
108	2-(5-CARBAMIMIDOYL-2-HYDROXY-BENZYLAMINO)-PROPIONIC ACID	A	1G3B	0.7
108	2-(5-CARBAMIMIDOYL-2-HYDROXY-BENZYLAMINO)-PROPIONIC ACID	A	1G3D	0.7
YTT	(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione	A	3G5H	0.71
AEH	4-(2-aminoethyl)-2-ethylphenol	A	3BUG	0.74
BPZ	4,4'-cyclohexane-1,1-diyldiphenol	A	2ZKC	0.72
AED	4-(2-aminoethyl)-2-cyclohexylphenol	A	3BUH	0.76
11N	1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine	A,B,C,D	2ZEC	0.73
HC6	(2S,2'S)-2,2'-biphenyl-4,4'-diylbis(2-hydroxy-4,4-dimethylmorpholin-4-ium)	A,B	3F2R	0.72
HC6	(2S,2'S)-2,2'-biphenyl-4,4'-diylbis(2-hydroxy-4,4-dimethylmorpholin-4-ium)	A,B	3G15	0.72
ALE	L-EPINEPHRINE	A	3PAH	0.73
ALE	L-EPINEPHRINE	A	2HKK	0.73
1OH	4-(1-methyl-1-phenylethyl)phenol	A	2ZAS	0.71
109	2-(4-CARBAMIMIDOYL-2-HYDROXY-BENZYLAMINO)-PROPIONIC ACID	A	1G3C	0.7
109	2-(4-CARBAMIMIDOYL-2-HYDROXY-BENZYLAMINO)-PROPIONIC ACID	A	1G3E	0.7
2OH	4,4'-PROPANE-2,2-DIYLDIPHENOL	A	2E2R	0.71
2OH	4,4'-PROPANE-2,2-DIYLDIPHENOL	A	2P7G	0.71
ARY	ARYLOMYCIN A2	A,B	1T7D	0.72
OTR	4-(2R-AMINO-1-HYDROXYETHYL)PHENOL	A,B	1RGT	0.72
OTR	4-(2R-AMINO-1-HYDROXYETHYL)PHENOL	A,B	1RG2	0.72
OTR	4-(2R-AMINO-1-HYDROXYETHYL)PHENOL	A,B	2AN4	0.72
HV7	1-METHYLAMINE-2-HYDROXY-4-METHOXY-BENZENE	C	1A8G	0.71
099	(2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide	A,B	3HYG	0.72
AEF	4-(2-aminoethyl)phenol	A	3BRA	0.71
BM4	3-[(3R)-3-ethyl-1-{9-[(3S)-3-ethyl-3-(3-hydroxyphenyl)azepan-1-yl]nonyl}azepan-3-yl]phenol	X	2W6C	0.79
RHP	(3R)-3-(PROP-2-YNYLAMINO)INDAN-5-OL	A,B	1S3E	0.74
REN	(S)-reticuline	A	3FWA	0.73
REN	(S)-reticuline	A	3D2D	0.73
OTS	4-(2S-AMINO-1-HYDROXYETHYL)PHENOL	A,B	1RG2	0.72
OTS	4-(2S-AMINO-1-HYDROXYETHYL)PHENOL	A,B	1RG1	0.72
OTS	4-(2S-AMINO-1-HYDROXYETHYL)PHENOL	A,B	1RH0	0.72
OTS	4-(2S-AMINO-1-HYDROXYETHYL)PHENOL	A,B	1RGU	0.72
OTS	4-(2S-AMINO-1-HYDROXYETHYL)PHENOL	A,B	1RGT	0.72
Y13	(2E)-3-(3,4-DIHYDROXYPHENYL)-N-[2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE	A	2EW6	0.73
SLX	(13aS)-3,10-dimethoxy-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline-2,9-diol	A	3FW9	0.73
RFX	(3R)-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine	A	3GWV	0.71
3QC	(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE	A,B	2FME	0.77
HXS	4-[(1R,2S)-1-ethyl-2-(4-hydroxyphenyl)butyl]phenol	A,B	3CV6	0.7
442	2-[3,5-DIBROMO-4-(4-HYDROXY-3-{HYDROXY[(2-PHENYLETHYL)AMINO]METHYL}PHENOXY)PHENYL]ETHANE-1,1-DIOL	A	1R6G	0.7
SFX	(3S)-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine	A	3GWW	0.71
LDP	L-DOPAMINE	A,B	2A3R	0.71
LDP	L-DOPAMINE	A	5PAH	0.71
LDP	L-DOPAMINE	A,B	2QMZ	0.71
LDP	L-DOPAMINE	A,B	2VQ5	0.71
BS2	(3-ENDO,8-ANTI)-8-BENZYL-3-(10,11-DIHYDRO-5H-DIBENZO[A,D][7]ANNULEN-5-YLOXY)-8-AZONIABICYCLO[3.2.1]OCTANE	A,D,E	2W8G	0.72
TXF	(Z)-4-(1-{4-[2-(DIMETHYLAMINO)ETHOXY]PHENYL}-5-HYDROXY-2-PHENYLPENT-1-ENYL)PHENOL	A,B,C,D,E	2EWP	0.7
SAF	3-[(1S)-1-(DIMETHYLAMINO)ETHYL]PHENOL	A	1GQR	0.74
SAF	3-[(1S)-1-(DIMETHYLAMINO)ETHYL]PHENOL	A	1GQS	0.74
IFA		A,B	3FC8	0.7
DPD		A,B	1QIW	0.75
DPD		A	1QIV	0.75
P12	4-[AMINO(IMINO)METHYL]-1-[2-(3-AMMONIOPROPOXY)-5-METHOXYBENZYL]PIPERAZIN-1-IUM	B	1UUI	0.7
SNP	1-(ISOPROPYLAMINO)-3-(1-NAPHTHYLOXY)-2-PROPANOL	A	1DY4	0.7
AHT	4-(2,5-DIAMINO-5-HYDROXY-PENTYL)-PHENOL	I,T	1TMB	0.73
AEG	4-[(2R)-2-aminopropyl]phenol	A	3BUF	0.72